Microsoft stock price today: MSFT ticks up on Bristol Myers AI lung-cancer imaging deal
Microsoft shares rose 0.7% to $459.86 Tuesday after Bristol Myers Squibb announced it will use Microsoft’s FDA-cleared AI radiology tools for early lung cancer detection. The move comes as Wall Street reopens from a holiday, with markets jittery over new tariff threats from President Trump. Microsoft’s Frankfurt-listed shares fell 2.2% Monday amid broader tech declines. The company reports fiscal Q2 earnings after markets close Jan. 28.